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HPK1 Is Activated by Lymphocyte Antigen
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interacting kinase (NIK; also referred to as HGK) (Su et
al., 1997; Yao et al., 1999), GCK-like kinase (GLK) (DienerThe serine/threonine kinase HPK1 is a member of the
et al., 1997), kinase homologous to SPS1/STE20 (KHS;germinal center kinase (GCK) family that has been
also referred to as GCKR) (Shi and Kehrl, 1997; Tungimplicated in the regulation of MAP kinase pathways.
and Blenis, 1997), and Drosophila Misshapen (Su et al.,Here, we demonstrate the involvement of HPK1 in anti-
1998). All GCKs contain N-terminal STE20-like kinasegen receptor signaling. Engagement of the TCR or the
domains and long C-terminal regulatory domains withBCR resulted in a marked induction of HPK1 catalytic
proline-rich motifs. STE20 is thought to function down-
activity. Subsequent analysis revealed that Src and
stream of a G protein and upstream of the MAP kinase
Syk/ZAP-70 tyrosine kinases and the adaptor proteins cascade in yeast (Herskowitz, 1995). Hence, STE20-like
LAT, SLP-76, BLNK, Grb2, and Grap are involved in proteins may link receptor activation to the regulation
HPK1 activation. Overexpression of HPK1 inhibited of MAP kinase modules. GCKs have been shown to be
TCR activation of AP-1 and ERK2, whereas the kinase- potent activators of the JNK pathway, although they
inactive mutant of HPK1 potentiated these responses. may well have additional biological functions.
Neither form of HPK1 affected PMA or v-Ras activation Among GCKs, HPK1 is of particular interest because
of AP-1 and ERK2. Thus, HPK1 is a negative regulator it is exclusively expressed in hematopoietic cells. Fur-
of the TCR-induced AP-1 response pathway. thermore, HPK1 was shown to interact with Grb2
(growth factor receptor binding protein 2) in vitro and
in a transfection model (Anafi et al., 1997). Grb2 is a
Introduction SH2/SH3 domain±containing adaptor protein that has
been implicated in coupling PTKs to the Ras pathway by
The stimulation of lymphocyte antigen receptors initi- its association with SOS, a guanine nucleotide exchange
ates a series of intracellular biochemical events leading factor (GEF) for Ras (Olivier et al., 1993; Simon et al.,
to the production of cytokines, cell proliferation, and 1993). In T cells, Grb2 is also complexed with signaling
differentiation (Weiss and Littman, 1994). In T lympho- regulators LAT, SLP-76, Cbl, Shc, and SOS as well as
cytes, engagement of the T cell receptor (TCR) activates the cytoplasmic tail of the T cell costimulatory receptor
Src and Syk/ZAP-70 families of protein tyrosine kinases CD28 (Schneider et al., 1995; Clements et al., 1999). The
(PTKs). Tyrosine phosphorylation of downstream sub- potential interaction between Grb2 and HPK1 raises the
strates such as the adaptor proteins LAT (linker for acti- possibility that HPK1 may be involved in T cell signaling.
vation of T cells) and SLP-76 (SH2 domain±containing In this report, we demonstrate that HPK1 is activated
leukocyte protein of 76 kDa), and the enzyme phospholi- following TCR and B cell receptor (BCR) stimulation.
pase Cg1 (PLCg1) contributes to the activation of Ras The signaling pathways linking receptor stimulation to
the activation of HPK1 in T and B cells are strikingly
similar. Furthermore, HPK1 suppresses TCR activationk To whom correspondence should be addressed (e-mail: aweiss@
medicine.ucsf.edu). of AP-1 and ERK2, while a kinase-inactive mutant of
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Figure 1. Activation of HPK1 Kinase Activity
by the TCR
(A) HPK1 activation by TCR stimulation.
Jurkat cells transfected with empty vector
(lane 1), HPK1:HA (lanes 2 and 3), or
HPK1(K46E):HA (lanes 4 and 5) were stimu-
lated with anti-TCR monoclonal antibody
(mAb) (1) or a buffer control (2) for 1 min.
Cells were then lysed, and anti-HA immune
complexes were assayed for kinase activity
using histone H2A as the exogenous sub-
strate. Phosphorylation was visualized by au-
toradiography (top and middle panels). The
fold stimulation of HPK1 activity, measured
by quantitating histone H2A phosphorylation
relative to that with mock-stimulated cells, is
indicated. The amount of HA-tagged HPK1
and HPK1(K46E) proteins immunoprecipi-
tated was detected by immunoblotting with
an anti-HPK1 antibody (bottom panel).
(B) Time course of TCR-induced HPK1 activa-
tion in Jurkat T cells. HPK1:HA-transfected
Jurkat cells were stimulated with anti-TCR
mAb for 0±20 min as indicated. HPK1 kinase
assays were performed as described in (A).
Shown is the average fold induction of HPK1
activity from two independent experiments.
(C) HPK1 activation in mouse lymph node T
cells. T cells purified from freshly isolated
mouse lymph nodes were stimulated with
anti-CD3 mAb for 0±15 min as indicated. Cells
were then lysed, and anti-mouse HPK1 im-
mune complexes were assayed for kinase ac-
tivity using histone H2A as the substrate.
Shown is the average fold induction of HPK1
activity from two independent experiments.
HPK1 potentiates these responses. This report charac- that HPK1 activation may be a relatively proximal event
in the TCR signaling pathway.terizes the activating pathway and the involvement of a
germinal center kinase in antigen receptor signal trans- We also examined the activation of HPK1 by the TCR
in freshly isolated mouse lymph node T cells. Consistentduction.
with the observations in Jurkat cells, the kinase activity
of endogenously expressed HPK1 was rapidly inducedResults
by CD3 cross-linking in purified mouse lymph node T
cells, although the magnitude of this response was lowerActivation of HPK1 by the TCR
To determine whether HPK1 plays a role in T cell activa- (Figure 1C). Together, these observations indicate that
HPK1 is involved in the signal transduction by the TCR.tion, we first examined the effect of TCR and CD28
stimulation on HPK1 kinase activity. Using an immune
complex kinase assay, we measured the kinase activity HPK1 Activation by the TCR Is Dependent on Lck,
ZAP-70, LAT, and SLP-76of HA-tagged HPK1 (HPK1:HA) following transient trans-
fection into Jurkat T cells. As shown in Figure 1A, HPK1 To identify upstream components of HPK1 in the TCR
signaling pathway, we examined HPK1 activation in mul-kinase activity was markedly induced by TCR stimula-
tion. However, neither the autophosphorylation of HPK1 tiple Jurkat signaling mutants. Since Lck and ZAP-70
are the most upstream components in TCR signaling,nor the phosphorylation of an exogenous substrate, his-
tone H2A, was observed with the kinase-inactive HPK1, we first focused on JCaM1, an Lck-deficient Jurkat de-
rivative (Straus and Weiss, 1992), and P116, a ZAP-70-HPK1(K46E), demonstrating the specificity of the kinase
assay. CD28 stimulation failed to activate HPK1 or mod- deficient Jurkat line (Williams et al., 1998). As expected,
based on the importance of Lck and ZAP-70 in TCRulate HPK1 activity induced by the TCR (data not
shown). An investigation of the time course of HPK1 signal transduction, inducible HPK1 activation was not
detected in either JCaM1 or P116 cells (Figure 2A). How-activation showed that HPK1 activity was induced 1
min following TCR stimulation and decreased thereafter ever, HPK1 was activated upon TCR stimulation in Lck-
reconstituted JCaM1 and ZAP-70-reconstituted P116(Figure 1B). These rapid and transient kinetics suggest
HPK1 Is Involved in Antigen Receptor Signaling
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protein kinase C (PKC) and Ras. Treatment of T cells
with PMA and ionomycin, a calcium ionophore, can
mimic TCR stimulation to induce downstream re-
sponses, including JNK activation and IL-2 gene tran-
scription, while bypassing proximal signaling events
such as tyrosine phosphorylation. However, neither of
these stimuli, alone or in combination, caused significant
HPK1 activation (Figure 2D). These results suggest that
HPK1 activation by the TCR may occur upstream or
independent of PKC, Ras, and calcium signaling.
HPK1 Interacts with Grb2 and Grap in T Cells
To further define the signaling pathway mediating HPK1
activation by the TCR, HPK1-interacting proteins in T
cells were examined. We metabolically labeled untrans-
fected and HPK1:HA-transfected cells with [35S]methio-
nine and cysteine. Cells were subsequently treated with
anti-TCR mAb, lysed, and anti-HA immunoprecipitations
were performed. Such analysis revealed several pro-
teins specifically associated with HPK1:HA (Figure 3A,
35S labeling). Two strong signals reproducibly detected
from immunoprecipitations of HPK1:HA were 100 kDa
and 28 kDa. The 100 kDa band was determined to be
HPK1:HA itself (Figure 3A, anti-HA blot). One candidate
for the 28 kDa band is the adaptor protein Grb2. By
immunoblotting, we found that Grb2 was present specif-Figure 2. TCR-Mediated HPK1 Activation Requires Lck, ZAP-70,
LAT, and SLP-76 ically in anti-HA immunoprecipitates from HPK1:HA-
(A±C) Jurkat, JCaM1 (Lck-deficient), and P116 (ZAP-70-deficient) transfected cells (Figure 3A, anti-Grb2 blot), and the
cells (A); JCaM2 and LAT-reconstituted JCaM2 (JCaM2/LAT) cells signal aligned exactly with the 28 kDa band detected
(B); or J14 and SLP-76-reconstituted J14 (J14-76) cells (C) were by metabolic labeling. Nevertheless, we cannot exclude
transfected with HPK1:HA and treated with anti-TCR mAb or a buffer
the possibility that the 28 kDa band may represent morecontrol for 1 min. Cells were then lysed, and anti-HA immunoprecipi-
than one HPK1-interacting protein. The proline-rich mo-tates were assayed for HPK1 kinase activity using histone H2A as
tifs in HPK1 were previously shown to interact with thethe substrate. The data shown are the average fold induction of
HPK1 activity from two independent experiments. In all experiments, SH3 domains of Grb2 in vitro (Anafi et al., 1997). In
there were equivalent amounts of HPK1 protein immunoprecipitated accord with this previous finding, we observed the pres-
as determined by immunoblotting. Cell surface expression of TCR ence of Grb2 in anti-HA immunoprecipitates from both
on all Jurkat lines was comparable.
resting and TCR-activated Jurkat cells transfected with(D) HPK1 is not activated by ionomycin or by PMA. HPK1:HA-trans-
HPK1:HA (Figure 3B).fected Jurkat T cells were stimulated for 1 min with anti-TCR mAb
We next performed reciprocal immunoprecipitationsor ionomycin (1 mM) and/or PMA (50 ng/ml). HPK1 catalytic activity
was measured as described above. The data shown are the average using an anti-Grb2 antibody. As shown in Figure 3C,
fold induction of HPK1 activity from two independent experiments. endogenously expressed HPK1 was detected in anti-
Grb2 immunoprecipitates from Jurkat cells regardless
of TCR stimulation, consistent with the results presented
in Figure 3B. To ensure that the association is specific,cells (data not shown). These results demonstrate that
Lck and ZAP-70 are required for HPK1 activation upon a control immunoprecipitation was performed in the
presence of an excess of the peptide epitope recognizedTCR stimulation.
We further analyzed HPK1 activation in JCaM2 cells by the anti-Grb2 antibody. Under these conditions, nei-
ther Grb2 nor HPK1 was detected in the immune com-in which LAT expression is greatly reduced (Finco et al.,
1998). In JCaM2 cells, HPK1 failed to be activated by plexes. Taken together, we have demonstrated that
Grb2 constitutively associates with HPK1 in T cells, andTCR stimulation. Importantly, reconstitution of LAT in
JCaM2 cells restored HPK1 activation following engage- it corresponds to the main HPK1-interacting protein
identified by metabolic labeling.ment of the TCR (Figure 2B). Moreover, HPK1 activation
was substantially reduced in J14 cells, a SLP-76-defi- The 28 kDa band observed by metabolic labeling
could also contain Grap, a Grb2-related adaptor protein.cient Jurkat T cell line (Yablonski et al., 1998), whereas
in J14 cells stably transfected with SLP-76 (J14-76), Grap shares the same size and overall structural charac-
teristics with Grb2 and is expressed predominantly inHPK1 was efficiently activated (Figure 2C). Together,
the data indicate that optimal HPK1 activation by TCR lymphoid tissues (Feng et al., 1996; TruÈ b et al., 1997).
To test whether HPK1 interacts with Grap, we immu-stimulation is dependent on the presence of the induc-
ibly tyrosine-phosphorylated adaptor proteins LAT and noblotted HPK1:HA immunoprecipitates with an anti-
Grap antibody. Similar to the results with Grb2, we de-SLP-76.
We next examined whether stimulation of the Ras tected a constitutive interaction between HPK1 and
Grap (Figure 3D). The anti-Grb2 and anti-Grap antibod-and calcium pathways are sufficient to induce HPK1
activation. PMA is a phorbol ester capable of activating ies we obtained do not cross-react, since they were
Immunity
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Figure 3. HPK1 Association with Grb2 in T Cells
(A) Examination of HPK1-interacting proteins in T cells. Untransfected (2) and HPK1:HA-transfected (1) Jurkat cells were metabolically labeled
with [35S]-methionine/cysteine and stimulated with anti-TCR mAb for 1 min prior to lysis. Anti-HA immunoprecipitates were resolved by SDS-
PAGE, transferred to a membrane, and visualized by autoradiography. The blot was subsequently probed with anti-HA and anti-Grb2 antibodies.
Positions of molecular mass markers are indicated in kilodaltons on the left.
(B) HPK1 associates with Grb2 constitutively in T cells. Untransfected (lanes 1 and 2) and HPK1:HA-transfected (lanes 3 and 4) Jurkat cells
were treated with a buffer control or anti-TCR mAb for 1 min. Cells were then lysed, immunoprecipitated with anti-HA mAb, and immunoblotted
with anti-HA (top panel) or anti-Grb2 (bottom panel) antibodies.
(C) The interaction between endogenously expressed HPK1 and Grb2. Jurkat cells were treated with a buffer control or anti-TCR mAb for 1
min, lysed, immunoprecipitated with an anti-Grb2 antibody in the absence (lanes 1 and 2) or presence (lanes 3 and 4) of a blocking peptide
to the anti-Grb2 antibody, and then immunoblotted with anti-HPK1 (top panel) or anti-Grb2 (bottom panel) antibodies.
(D) HPK1 associates with Grap in T cells. Untransfected (lanes 1 and 2) and HPK1:HA-transfected (lanes 3 and 4) Jurkat cells were treated
with a buffer control or anti-TCR mAb for 1 min. Cells were then lysed, immunoprecipitated with anti-HA mAb, and immunoblotted with anti-
HA (top panel) or anti-Grap (bottom panel) antibodies.
generated against the divergent C-terminal residues completely abrogated (Figure 4B). Interestingly, BCR-
mediated Btk activation is also partially impaired in Lynwithin the two proteins. Together, the data demonstrate
and Syk single-deficient cells and is absent in Lyn/Sykthat HPK1 interacts with both Grb2 and Grap in T cells
double-deficient DT40 cells (Kurosaki and Kurosaki,and, therefore, suggest that Grb2 and Grap may play
1997). Nevertheless, the activation of HPK1 in Btk-defi-redundant roles in regulating HPK1 activation.
cient DT40 cells was only slightly reduced when com-
pared to wild-type cells (Figure 4B). These results indi-
Activation of HPK1 by the BCR
cate that Btk is not required for HPK1 activation,
To further explore the role of Grb2 and Grap in HPK1 although both HPK1 and Btk depend on Src and Syk
activation, we took advantage of a genetic system devel- family kinases as upstream regulators. Together with
oped in the avian B cell line DT40. Many mutants of this the findings presented in Figure 2A, the data suggest
cell line have been established by homologous recombi- that HPK1 activation by lymphocyte antigen receptors
nation that specifically targets genes of interest. In par- depends on Src and Syk family kinases but not Btk
ticular, Grb2-, Grap-, and Grb2/Grap double-deficient family kinases.
DT40 cells have been generated. The signal transduc- B cell linker protein (BLNK) is a SLP-76 homolog in B
tion events following ligation of the TCR or the BCR are cells that, like SLP-76, links upstream tyrosine kinases
quite similar. Since HPK1 appears to be a downstream to downstream signaling events (Fu et al., 1998; Ishiai
target in TCR signaling and is expressed in B cells (Kiefer et al., 1999). Consistent with the results obtained with
et al., 1996), we examined whether BCR stimulation in- SLP-76-deficient T cells (Figure 2C), HPK1 activation
duces HPK1 activation in DT40 cells. As shown in Figure was severely impaired by the loss of BLNK in DT40 cells
4A, stimulation of the BCR evoked a potent induction (Figure 4C). These results demonstrate the importance
of HPK1 kinase activity with kinetics similar to that with of SLP-76-like linker proteins in HPK1 activation by T
TCR stimulation. Thus, we were able to extend our inves- and B lymphocyte antigen receptors.
tigation of HPK1 activation to the BCR signaling path- In Figure 3, we have demonstrated that HPK1 interacts
way. We first focused on DT40 mutants lacking protein with the adaptor proteins Grb2 and Grap in Jurkat T
tyrosine kinases, including Lyn, Syk, and Btk. We found cells. To test whether Grb2 or Grap is required for HPK1
that the level of HPK1 activation was partially decreased activation, kinase assays were performed with Grb2-,
in either Lyn- or Syk-deficient DT40 cells, while in Lyn/ Grap-, and Grb2/Grap double-deficient DT40 cells. Sig-
nificant levels of HPK1 activation were still detectedSyk double-deficient DT40 cells, HPK1 activation was
HPK1 Is Involved in Antigen Receptor Signaling
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Figure 4. HPK1 Activation by the BCR
(A) HPK1 activation by BCR stimulation. Wild-
type DT40 B cells transfected with HPK1:HA
were treated with anti-BCR mAb for 0±20 min
as indicated. Anti-HA immune complexes
were assayed for HPK1 kinase activity using
histone H2A as the substrate. Shown is the
fold induction of HPK1 activity measured by
quantitating histone H2A phosphorylation rel-
ative to that with mock-stimulated cells. The
average and standard error shown are from
three independent experiments.
(B±E) HPK1 activation in DT40 mutants. Vari-
ous DT40 cells were transiently transfected
with HPK1:HA, stimulated with anti-BCR mAb
for 2 min, and HPK1 kinase assays were per-
formed as described in (A). The average and
standard error shown are from three indepen-
dent experiments. Equivalent levels of HPK1
protein were immunoprecipitated in all kinase
assays. BCR expression on the surface of
various DT40 cell lines was comparable.
in Grb2 and Grap single-deficient cell lines; however, complex (Karin et al., 1997). Since HPK1 potentiated
almost a complete absence of HPK1 activation was ob- JNK activation in T cells, it was of interest to test its
served in Grb2/Grap double-deficient cells (Figure 4D). effect on AP-1 induction. To analyze AP-1 transcriptional
These results indicate that both Grb2 and Grap may activation, cells were cotransfected with HPK1 and an
participate and play redundant roles in HPK1 activation. AP-1-driven luciferase reporter and subsequently stimu-
PLCg2 is involved in the activation of the phosphati- lated with anti-TCR mAb. Surprisingly, we observed that
dylinositol pathway following BCR engagement. In PLCg2- HPK1 inhibited AP-1 activation by the TCR in a dose-
deficient DT40 cells, stimulation of the BCR failed to dependent manner. In contrast, AP-1 activation by PMA
induce inositol 1,4,5-triphosphate (IP3) production and treatment, which bypasses proximal TCR signaling
calcium mobilization (Takata et al., 1995). To test events to activate PKC and Ras, was not affected by
whether these two signaling events are required for HPK1 (Figure 6A). This selective inhibition of TCR but
HPK1 activation, we assessed HPK1 catalytic activity not PMA activation of AP-1 suggests that HPK1 either
upon BCR stimulation in PLCg2-deficient DT40 cells. affects the TCR signaling pathway upstream of PKC or
Normal levels of HPK1 activation were observed in these Ras activation or acts on a TCR-induced AP-1 activating
cells (Figure 4E). This result, together with the findings pathway independent of PKC and Ras. Overexpression
presented in Figure 2D, imply that calcium mobilization of the kinase-inactive mutant HPK1(K46E) did not inhibit
alone or in combination with the activation of PKC or Ras TCR-mediated AP-1 activation but slightly potentiated
is neither necessary nor sufficient for HPK1 activation by it (Figure 6B). These results demonstrate that the kinase
lymphocyte antigen receptors. activity of HPK1 is essential for its negative regulatory
effect on AP-1.
Overexpression of HPK1 Activates JNK1 in T Cells One possible explanation for this inhibitory effect is
Previous reports have demonstrated that ectopic ex- that persistent activation of JNK resulting from HPK1
pression of HPK1 in fibroblasts induces JNK activation overexpression could downregulate AP-1 through a
(Hu et al., 1996; Kiefer et al., 1996). To examine whether negative feedback mechanism. To test this possibility,
HPK1 activates JNK in T cells, we cotransfected ex- we expressed a constitutively active form of JNK1, rep-
pression vectors encoding Myc-tagged HPK1 and HA-
resenting a fusion between JNK1 and MKK7 (A. D. and
tagged JNK1 into Jurkat cells. Subsequently, cells were
M. H. C., unpublished data; Zheng et al., 1999), in Jurkatstimulated with a combination of anti-TCR and anti-
cells and assessed AP-1 activation. Unlike HPK1, JNK1-CD28 mAbs, or PMA and ionomycin. JNK kinase assays
MKK7 upregulated both TCR and PMA activation ofwere performed with anti-HA immunoprecipitates using
AP-1 (Figure 6C). These results suggested that HPK1GST-c-Jun as the exogenous substrate. Phosphoryla-
exerts an additional activity to inhibit AP-1 other thantion of the substrate was then monitored by immunoblot-
its effect on JNK activation.ting with an anti-phospho-c-Jun antibody. As shown in
Figure 5, overexpression of HPK1 triggered JNK1 activa-
HPK1 Inhibits ERK2 Activation by the TCRtion when expressed at a high dose (Figure 5, lane 10).
but Not by v-RasMoreover, HPK1 further potentiated JNK activities in-
ERK, another MAP kinase capable of regulating AP-1duced by the costimulation of TCR and CD28 receptor
activity, is activated following TCR stimulation (Cantrell,or PMA plus ionomycin (Figure 5). These results are
1996). To examine whether HPK1 affects ERK activationconsistent with the notion raised in previous studies that
by the TCR, we cotransfected expression vectors en-HPK1 is a potent activator for the JNK pathway.
coding HA-tagged HPK1 and Myc-tagged ERK2 into
Jurkat cells and examined ERK2 phosphorylation uponHPK1 Suppresses AP-1 Activation by the TCR
TCR stimulation. Similar to the results obtained withbut Not by PMA
AP-1 activation, TCR-mediated ERK2 phosphorylationDownstream targets of JNK such as c-Jun and ATF2
are integral components of the AP-1 transcription factor was reduced in HPK1-transfected cells (Figure 7A),
Immunity
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Figure 5. Overexpression of HPK1 Activates
JNK in T Cells
Jurkat cells were cotransfected with 20 mg of
HA-tagged JNK1 and 0±10 mg of Myc-tagged
HPK1 expression plasmids as indicated. Six
hours later, cells were stimulated for 15 min
with a buffer control (lanes 1, 4, 7, and 10),
anti-TCR plus anti-CD28 antibodies (lanes 2,
5, 8, and 11), or PMA (50 ng/ml) plus iono-
mycin (1 mM) (lanes 3, 6, 9, and 12). JNK
assays were performed on anti-HA immuno-
precipitates using GST-c-Jun as the exoge-
nous substrate. Phosphorylation of the substrate was measured by immunoblotting with an anti-phospho-c-Jun antibody (top panel). The
amount of HA-tagged JNK1 protein immunoprecipitated was examined using an anti-JNK1 antibody (bottom panel).
whereas the kinase-inactive HPK1 significantly potenti- possess SH2 domains. One possibility is that LAT, SLP-
76, and BLNK contribute to HPK1 activation indirectlyated ERK2 phosphorylation induced by the TCR (Figure
7B). Neither wild-type nor kinase-inactive HPK1 affected by facilitating antigen receptor signaling. Another expla-
nation is that these linker proteins are coupled to HPK1ERK2 activation by PMA (Figure 7A and 7B). We also
utilized an activated allele of Ras, v-Ha-Ras, which is by SH2 domain±containing proteins, thereby recruiting
HPK1 to the receptor signaling complexes where it canmutated at codon 12 (Ser ! Val) and 59 (Ala ! Thr)
resulting in a constitutively active Ras, to activate ERK2 be activated.
Indeed, we found that the SH2/SH3 domain±con-and found that the activation was not affected by either
wild-type or kinase-inactive HPK1 (Figure 7C). The data taining adaptor proteins Grb2 and Grap are also involved
in the signal transduction process leading to HPK1 acti-presented in Figure 6 and Figure 7 provide compelling
evidence that HPK1 acts as a negative regulator of the vation. Grb2 was identified as the 28 kDa protein associ-
ated with HPK1 in metabolically labeled Jurkat T cells.ERK2/AP-1 pathway in TCR signal transduction.
Both Grb2 and Grap were found to interact with HPK1
constitutively in T cells. These biochemical data wereDiscussion
complemented by genetic data obtained with the avian
DT40 B cell line and its mutants. Although a normalGCK family kinases (GCKs) are recently identified con-
stituents of MAP kinase pathways and are therefore level of HPK1 activation was observed in Grb2 and Grap
single-deficient DT40 cells, this activation was greatlypotential regulators for AP-1. The hematopoietic tissue-
restricted expression pattern and the ability to interact diminished in Grb2/Grap double-deficient cells. These
results indicate that Grb2 and Grap may play redundantwith Grb2 led us to focus on the role of HPK1 in T
cell signaling. Here, we show that HPK1 is activated roles in BCR-mediated HPK1 activation. Grb2 and Grap
have been shown to associate with LAT upon TCR stim-following engagement of lymphocyte antigen receptors.
We further demonstrate that HPK1 inhibits AP-1 and ulation (TruÈ b et al., 1997; Zhang et al., 1998). Therefore,
these SH2/SH3 domain±containing adaptors may func-ERK2 activation by TCR stimulation. Hence, HPK1 is
the first reported GCK family kinase that participates in tion to couple HPK1 to tyrosine-phosphorylated pro-
teins such as LAT in the activated receptor complex.antigen receptor signaling and functions as a negative
regulator for the TCR-mediated AP-1 activation. Based on the above observations, we postulate the
following mechanism of HPK1 activation in T cells. TCRIn this study, we have characterized a pathway, con-
served in T and B lymphocytes, that relays signals from ligation activates Lck resulting in the activation of ZAP-
70. ZAP-70 in turn phosphorylates LAT, which recruitsreceptor cross-linking to the induction of HPK1 kinase
activity. Previously, HPK1 has been shown to be acti- Grb2-HPK1 and Grap-HPK1 complexes to the TCR sig-
nal transduction machinery. HPK1 is then activated ei-vated by erythropoietin (Epo) (Nagata et al., 1999) and
TGFb (Zhou et al., 1999). However, the signaling path- ther by membrane localization to the proximity of an
activator or by oligomerization leading to transauto-way linking receptor stimulation to HPK1 activation was
not defined. Using cell lines deficient in Src and Syk/ phosphorylation. Consistent with this model, an induc-
ible 36±38 kDa tyrosine-phosphorylated protein thatZAP-70 families of PTKs, we found that Lck and ZAP-
70 are essential for HPK1 activation in T cells. Similarly, likely corresponds to LAT was detected in anti-HA im-
munoprecipitates from HPK1:HA-transfected cells (dataLyn and Syk participate in HPK1 activation in B cells.
Src and Syk/ZAP-70 PTKs may play a role by phosphory- not shown). SLP-76 may facilitate signaling events
within the TCR-regulated signaling complex, therebylating HPK1 directly or by activating upstream regulators
of HPK1. Since we have not been able to detect tyrosine participating in HPK1 activation. A similar mechanism
appears to be employed by the BCR in activating HPK1.phosphorylation of HPK1 upon TCR stimulation (data
not shown), it is likely that these tyrosine kinases may In addition to HPK1, other GCKs including GCK and
GCKR are also expressed in lymphocytes. It is notactivate HPK1 indirectly.
Next, we identified inducibly tyrosine-phosphorylated known whether lymphocyte antigen receptors activate
GCK family kinases other than HPK1. GCK and GCKRlinker proteins LAT, SLP-76, and BLNK as critical com-
ponents for antigen receptor±mediated HPK1 activa- have been shown to be activated by TNFa (Pombo et
al., 1995; Shi and Kehrl, 1997); however, HPK1 does nottion. Tyrosine phosphorylation of these three molecules
provides docking sites for SH2 domain±containing pro- respond to TNFa stimulation (data not shown; Hu et al.,
1996). These results suggest that GCK family kinasesteins, thus promoting the translocation or phosphoryla-
tion of downstream effectors. However, HPK1 does not may be differentially regulated by various receptors.
HPK1 Is Involved in Antigen Receptor Signaling
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Figure 7. HPK1 Suppresses ERK2 Activation by TCR Stimulation
(A and B) Jurkat cells were transfected with 0±5 mg of HPK1:HA (A)
or HPK1(K46E):HA (B) expression plasmids as indicated together
with 15 mg of expression vector encoding Myc-tagged ERK2. Six
hours after transfection, cells were stimulated for 5 min with a buffer
control (lanes 1, 4, and 7), anti-TCR mAb (lanes 2, 5, and 8), or PMA
(50 ng/ml) (lanes 3, 6, and 9). ERK2 phosphorylation was assessed
by anti-Myc immunoprecipitation followed by immunoblotting with
an anti-phospho-ERK1/2 antibody (top panel). The expression level
Figure 6. HPK1 Selectively Inhibits TCR but Not PMA Activation of of Myc-tagged ERK2 protein was examined using anti-Myc mAb
AP-1 (bottom panel). These experiments were repeated at least three
times with similar results.Jurkat cells were transfected with 0±10 mg of HPK1:HA (A) or
HPK1(K46E):HA (B), or 0±25 mg of HA JNK1-MKK7 (C) expression (C) HPK1 does not affect ERK2 activation by v-Ras. Jurkat T cells
were cotransfected with 15 mg of Myc-tagged ERK2 and 5 mg ofplasmid as indicated together with 20 mg of AP-1 luciferase and 2
mg of b-galactosidase reporter constructs. Total DNA concentration HPK1:HA or HPK1(K46E):HA expression plasmids with or without
10 mg of v-Ha-ras expression vector. Total DNA concentration waswas kept constant using the empty expression vector. Sixteen hours
after transfection, cells were stimulated with medium, anti-TCR kept constant using empty expression vectors. Six hours later, cells
were lysed, and ERK2 phosphorylation was assessed as describedmAb, or PMA for 6 hr. Cell lysates were then prepared and assayed
for luciferase activity. Shown is the average and standard error of above (top panel). The amount of Myc-tagged ERK2 protein immu-
noprecipitated was detected using an anti-ERK2 antibody (bottomtriplicate measurements, normalized as the percentage induction
of luciferase activity of vector-transfected cells treated with the panel).
activating stimulus. b-galactosidase activity was used to normalize
the transfection efficiency. Similar results were obtained with a mini-
mum of three independent experiments. The expression of HA- clear that at least some other signaling pathways in
tagged proteins was examined by immunoblotting with anti-HA mAb. addition to HPK1 activation are required to activate JNK
in T cells. Notably, the combination of ionomycin and
PMA failed to activate HPK1 but potently activated JNKEctopic expression of HPK1 in fibroblasts can activate
JNK (Hu et al., 1996; Kiefer et al., 1996). Although we in T cells. This indicates that the activation of JNK, in-
duced by the combination of PMA and ionomycin, isobserved the JNK stimulatory function of HPK1 in T
cells, the kinase-inactive (K46E) or a kinase domain± not dependent on HPK1.
Intriguingly, our data indicate that HPK1 inhibited AP-1deleted mutant of HPK1 failed to block JNK activation
following TCR plus CD28 or PMA plus ionomycin stimu- and ERK2 activation upon TCR stimulation. One group
recently reported that overexpression of two mutantlation (data not shown). One interpretation of these find-
ings is that HPK1 does not regulate JNK activation fol- forms of HPK1 resulted in a reduction of the IL-2 pro-
moter activity in Jurkat cells (Ling et al., 1999). However,lowing TCR stimulation. Moreover, stimulation of the
TCR is sufficient to activate HPK1, but JNK activation the upstream and downstream pathways of HPK1 in T
cell signaling were not clearly defined. In this report, weis not activated by TCR stimulation alone. Thus, it is
Immunity
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Anti-phospho-ERK1/2 antibody was from New England Biolabs.defined signaling pathways mediating HPK1 activation
Anti-ERK2 antibody was from Zymed. Anti-mouse HPK1 antibodiesby the TCR and BCR. In addition, we examined the effect
were previously described (Kiefer et al., 1996). pcdef3-HPK1:HA andof HPK1 on TCR activation of AP-1 as well as ERK
pcdef3-HPK1(K46E):HA were constructed by subcloning HindIII±
and JNK MAP kinases. We observed a dose-dependent ScaI fragments containing HPK1 cDNA from pMT2-HPK1:HA and
inhibition of TCR-mediated AP-1 activation by wild-type pMT2-HPK1(K46E):HA (Kiefer et al., 1996) into pcdef3 vector. pEF-
BOS-HPK1-Myc was kindly provided by D. Qian (SUGEN, San Fran-HPK1, whereas a kinase-inactive mutant of HPK1 not
cisco, CA). The Myc-tagged ERK2 expression construct has beenonly failed to suppress AP-1 activation but even exerted
previously described (Qian et al., 1996). pSRa-HA-JNK1 and thea stimulatory effect, perhaps due to the competition for
b-galactosidase reporter construct driven by the b-actin promotersubstrates with endogenous HPK1 in T cells. Therefore,
were gifts from M. Karin (University of California, San Diego, CA).
it appears that the negative regulatory effect of HPK1 on pCEP4HA JNK1-MKK7 was constructed by A. Dang and will be
AP-1 activation is associated with its catalytic activity. described in detail elsewhere. pEF v-Ha-ras was a gift from D. Can-
trell (Imperial Cancer Research Fund, UK). The AP-1 reporter plas-Importantly, similar results were observed with TCR-
mid was described previously (Shapiro et al., 1996).mediated ERK2 activation, suggesting that HPK1 may
inhibit AP-1 through its effect on the ERK pathway. This
Cell Culture and Transfectioninhibition seems to occur upstream or independent of
The Jurkat (human T cell leukemia) line E61 (Weiss et al., 1984) andPKC and Ras, since neither form of HPK1 affected PMA
the signaling mutant derivatives JCaM1 (Goldsmith et al., 1988),
or v-Ras activation of AP-1 and ERK2. Similar functional P116 (Williams et al., 1998), JCaM2 (Goldsmith et al., 1988), JCaM2/
effects of wild-type and kinase-inactive HPK1 were ob- LAT (Finco et al., 1998), J14, and J14-76 (Yablonski et al., 1998)
served with NFAT and CD28RE/AP-1 transcriptional re- were maintained in RPMI 1640 supplemented with 5% fetal calf
serum (FCS), penicillin, streptomycin, and glutamine. DT40 cell linesporters that are dependent upon AP-1 binding, further
deficient for Lyn (Takata et al., 1994), Syk (Takata et al., 1994), Lyn/confirming the inhibitory function of HPK1 on AP-1 (data
Syk (Takata and Kurosaki, 1996), BTK (Takata and Kurosaki, 1996),not shown).
BLNK (Ishiai et al., 1999), Grb2 (Hashimoto et al., 1998), Grap (Hashi-
One interpretation for the negative regulatory effect moto et al., 1998), Grb2/Grap (generated by A. Hashimoto and will
of HPK1 on ERK2/AP-1 activation is that it may compete be described in detail elsewhere), and PLCg2 (Takata et al., 1995)
with SOS for available Grb2. However, the kinase-inac- were maintained in the medium described above supplemented
with 1% chicken serum. Transient transfections of Jurkat cells weretive HPK1 that potentiates ERK and AP-1 activation by
performed by electroporating 2 3 107 cells resuspended in 400 mlthe TCR is still capable of binding to Grb2 constitutively
serum-free RPMI 1640 medium with the indicated amount of DNAin T cells (data not shown). Therefore, it is unlikely that
in a 0.4 cm cuvette using the Gene Pulser (Bio-Rad Laboratories)
HPK1 exerts its effect by competing with Grb2 effectors. at a setting of 250 V, 960 mF. For DT40 transfections, 2 3 107 cells in
Moreover, the Grb2/SOS complex may not represent 450 ml serum-free RPMI 1640 were electroporated at 350 V, 500 mF.
the predominant means for antigen receptor±mediated
Ras/ERK/AP-1 activation in lymphocytes. Instead, PLCg Cell Stimulation, Preparation of Lysates, Immunoprecipitation,
and Immunoblottingand Ras GRP may play more important roles (Ebinu et
Cells were washed once with phosphate-buffered saline (PBS), thenal., 1998; Hashimoto et al., 1998; Yablonski et al., 1998).
incubated at 378C for 15 min. Subsequently, cells were either mock-It will be interesting to test whether the activation of
stimulated with PBS (buffer control) or were stimulated for the time
these effectors by the TCR is affected by HPK1. Further indicated with various antibodies, 4 b-phorbol 12-myristate 13-ace-
investigations are required to identify the target(s) of tate (PMA) (50 ng/ml), or ionomycin (1 mM). Cells were lysed in cold
HPK1 in the ERK2/AP-1 activation pathway. lysis buffer (1% Nonidet P-40, 10 mM Tris [pH 7.6], 150 mM NaCl)
supplemented with protease and phosphatase inhibitors on ice forThe AP-1 pathway is specifically blocked in anergic
20 min. Precleared lysates were incubated with antibody-precou-T cells (Kang et al., 1992). Since HPK1 is activated by
pled Protein A- or G-sepharose beads for 2 hr at 48C. The immuno-the TCR and negatively regulates AP-1 signaling in T
precipitates were then washed four times with lysis buffer, resus-
cells, it is possible that HPK1 plays a role in the induction pended in SDS sample buffer, and heated at 958C for 5 min.
and/or the maintenance of the status of T cell anergy. Immunoprecipitated proteins were separated by SDS-PAGE, trans-
Antagonizing signals such as HPK1 activated by the ferred to Immobilon-P membrane (Millipore), and probed with pri-
mary and secondary antibodies followed by enhanced chemilumi-TCR could orchestrate with positive signals to determine
nescence detection (Amersham).the magnitude and the outcome of TCR signaling. There-
fore, it will be of interest to examine the kinase activity
Immune Complex Kinase Assaysand expression of HPK1 in T cells at various stages of
For HPK1 kinase assays, 5 3 106 Jurkat or DT40 cells transfecteddevelopment and differentiation. Finally, generation of
with 2 mg of pcdef3-HPK1:HA, or 16 3 106 purified mouse lymph
HPK1-deficient cell lines and animals should comple- node T cells were stimulated with anti-TCR, anti-BCR, or anti-CD3
ment our study to understand the functions of HPK1. mAb, respectively, and then lysed in cold lysis buffer A (Kiefer et
al., 1996). Precleared lysates were immunoprecipitated with anti-HA
or anti-mouse HPK1 antibody precoupled to Protein A-sepharoseExperimental Procedures
beads. Immunoprecipitates were assayed for kinase activities as
described previously (Kiefer et al., 1996) with the addition of 5 mg ofReagents
The antibodies used for the stimulation of T cells were C305 (anti- histone H2A as the exogenous substrate. Kinase reaction products
were separated by SDS-PAGE, transferred to Immobilon-P mem-Jurkat Ti b chain mAb) (Weiss and Stobo, 1984), 145-2C11 (anti-
mouse CD3 e chain mAb) (American Type Culture Collection), and brane, and visualized by autoradiography and phosphorimaging.
For JNK assays, Jurkat cells were cotransfected with 20 mg of pSRa-mouse mAb to human CD28 (CALTAG). M4 (anti-chicken B cell
receptor mAb) was a gift from M. Cooper and C. L. Chen (University HA-JNK1 and 10 mg of other indicated plasmids. Six hours after
transfection, 7 3 106 cells were stimulated for 15 min with PBS, aof Alabama, Birmingham, AL). 12CA5 (anti-HA epitope mAb) was
from Boehringer Mannheim. 9E10 (anti-Myc epitope mAb) was a gift combination of anti-TCR and anti-CD28 antibodies, or a combina-
tion of PMA (50 ng/ml) and ionomycin (1 mM). Nonradioactive JNKfrom J. M. Bishop (University of California, San Francisco, CA). 4G10
(anti-phosphotyrosine mAb) was from Upstate Biotechnology. Anti- assays were performed according to the instruction manual of the
manufacturer (New England Biolabs).Grb2 and anti-Grap antibodies were from Santa Cruz Biotechnology.
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Metabolic Labeling with [35S]-Methionine/Cysteine Herskowitz, I. (1995). MAP kinase pathways in yeast: for mating and
more. Cell 80, 187±197.Cells were washed twice with methionine- and cysteine-free RPMI
1640 (ICN), then starved 30 min in the same medium supplemented Hu, M.C., Qiu, W.R., Wang, X., Meyer, C.F., and Tan, T.H. (1996).
with 5% dialyzed FCS. [35S]-methionine/cysteine (Tran35S-label; ICN) Human HPK1, a novel human hematopoietic progenitor kinase that
was added at 125 mCi/ml. After incubation at 378C for 2 hr, cells activates the JNK/SAPK kinase cascade. Genes Dev. 10, 2251±2264.
were washed twice with PBS, stimulated with anti-TCR mAb for 1 Ishiai, M., Kurosaki, M., Pappu, R., Okawa, K., Ronko, I., Fu, C.,
min, and lysed. Precleared lysates were immunoprecipitated with Shibata, M., Iwamatsu, A., Chan, A.C., and Kurosaki, T. (1999). BLNK
preformed antibody complexes containing anti-HA mAb at 48C for required for coupling Syk to PLCg2 and Rac1-JNK in B cells. Immu-
2 hr. Washed immunoprecipitates were analyzed by SDS-PAGE, nity 10, 117±125.
transferred to Immobilon-P membrane, and visualized by autoradi-
Jain, J., Loh, C., and Rao, A. (1995). Transcriptional regulation ofography.
the IL-2 gene. Curr. Opin. Immunol. 7, 333±342.
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Luciferase Assays
Lenardo, M.J. (1992). Transactivation by AP-1 is a molecular target
Jurkat cells were transiently cotransfected with 20 mg of AP-1 lucif-
of T cell clonal anergy. Science 257, 1134±1138.
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porter Gene Assay System (TROPIX). of a novel protein kinase in human B lymphocytes. Preferential local-
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